[go: up one dir, main page]

DD129325A5 - Verfahren zur herstellung von 2-hydroxymethyl-3-hydroxy-6-(1-hydroxy-2-teert.-butylaminoaethyl)-pyridin - Google Patents

Verfahren zur herstellung von 2-hydroxymethyl-3-hydroxy-6-(1-hydroxy-2-teert.-butylaminoaethyl)-pyridin

Info

Publication number
DD129325A5
DD129325A5 DD7600195004A DD19500476A DD129325A5 DD 129325 A5 DD129325 A5 DD 129325A5 DD 7600195004 A DD7600195004 A DD 7600195004A DD 19500476 A DD19500476 A DD 19500476A DD 129325 A5 DD129325 A5 DD 129325A5
Authority
DD
German Democratic Republic
Prior art keywords
hydroxy
teert
butylaminoaethyl
hydroxymethyl
pyridine
Prior art date
Application number
DD7600195004A
Other languages
English (en)
Inventor
Ronnie D Carroll
James R Tretter
Bernard S Moore
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of DD129325A5 publication Critical patent/DD129325A5/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/63One oxygen atom
    • C07D213/65One oxygen atom attached in position 3 or 5

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DD7600195004A 1975-10-03 1976-09-27 Verfahren zur herstellung von 2-hydroxymethyl-3-hydroxy-6-(1-hydroxy-2-teert.-butylaminoaethyl)-pyridin DD129325A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/619,302 US4011231A (en) 1975-10-03 1975-10-03 2-Phenyl-6-(1-hydroxy-2-t-butylaminoethyl)-4H-pyrido[3,2-d]-1,3-dioxin maleate and its use as an intermediate

Publications (1)

Publication Number Publication Date
DD129325A5 true DD129325A5 (de) 1978-01-11

Family

ID=24481329

Family Applications (2)

Application Number Title Priority Date Filing Date
DD7600195004A DD129325A5 (de) 1975-10-03 1976-09-27 Verfahren zur herstellung von 2-hydroxymethyl-3-hydroxy-6-(1-hydroxy-2-teert.-butylaminoaethyl)-pyridin
DD7600202338A DD133672A5 (de) 1975-10-03 1976-09-27 Verfahren zur herstellung eines saeureadditionssalzes

Family Applications After (1)

Application Number Title Priority Date Filing Date
DD7600202338A DD133672A5 (de) 1975-10-03 1976-09-27 Verfahren zur herstellung eines saeureadditionssalzes

Country Status (30)

Country Link
US (1) US4011231A (de)
JP (1) JPS5246081A (de)
AR (1) AR213180A1 (de)
AT (1) AT353789B (de)
BE (1) BE846471A (de)
BG (1) BG27544A3 (de)
CA (1) CA1059518A (de)
CH (1) CH616424A5 (de)
CS (2) CS205041B2 (de)
DD (2) DD129325A5 (de)
DE (1) DE2640123C3 (de)
DK (1) DK147049C (de)
ES (2) ES451746A1 (de)
FI (1) FI64354C (de)
FR (1) FR2326191A1 (de)
GB (1) GB1510075A (de)
GR (1) GR61628B (de)
HU (2) HU172998B (de)
IE (1) IE43503B1 (de)
LU (1) LU75898A1 (de)
NL (1) NL164274C (de)
NO (1) NO147027C (de)
PH (1) PH14511A (de)
PL (1) PL106863B1 (de)
PT (1) PT65619B (de)
RO (1) RO69886A (de)
SE (2) SE428127B (de)
SU (2) SU673168A3 (de)
YU (1) YU39545B (de)
ZA (1) ZA765253B (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4632992A (en) * 1981-02-09 1986-12-30 Pfizer Inc. Intermediates for preparing pirbuterol and analogs
US4477671A (en) * 1981-02-09 1984-10-16 Pfizer Inc. 3-Acetoxy or benzyloxy-2-acetoxymethyl-6-[1-acetoxy-2-(N-tert-butylacetamido)ethyl]pyridine intermediates
US5395939A (en) * 1993-11-30 1995-03-07 North Carolina State University Method of making asymmetric de ring intermediates for the synthesis of camptothecin and camptothecin analogs

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3250778A (en) * 1962-11-29 1966-05-10 Hoffmann La Roche Intermediates for and synthesis of vitamin b and related compounds
US3700681A (en) * 1971-02-16 1972-10-24 Pfizer 2-hydroxymethyl-3-hydroxy-6-(1-hydroxy-2-aminoethyl)pyridines

Also Published As

Publication number Publication date
FI64354B (fi) 1983-07-29
AT353789B (de) 1979-12-10
IE43503B1 (en) 1981-03-11
BG27544A3 (en) 1979-11-12
PT65619A (en) 1976-10-01
NL164274C (nl) 1980-12-15
DK434176A (da) 1977-04-04
NL7610683A (nl) 1977-04-05
JPS5519210B2 (de) 1980-05-24
SE7609497L (sv) 1977-04-04
PL106863B1 (pl) 1980-01-31
YU216576A (en) 1982-06-30
IE43503L (en) 1977-04-03
ZA765253B (en) 1977-08-31
HU177493B (en) 1981-10-28
NL164274B (nl) 1980-07-15
CS205042B2 (en) 1981-04-30
DE2640123C3 (de) 1980-09-25
GR61628B (en) 1978-12-04
US4011231A (en) 1977-03-08
ES457257A1 (es) 1978-02-01
DD133672A5 (de) 1979-01-17
AU1788376A (en) 1978-03-16
DE2640123B2 (de) 1980-01-31
SE437159B (sv) 1985-02-11
LU75898A1 (de) 1977-05-11
SU673168A3 (ru) 1979-07-05
FI64354C (fi) 1983-11-10
DK147049B (da) 1984-03-26
CS205041B2 (en) 1981-04-30
JPS5246081A (en) 1977-04-12
BE846471A (fr) 1977-03-23
NO763307L (de) 1977-04-05
HU172998B (hu) 1979-01-28
YU39545B (en) 1984-12-31
FR2326191B1 (de) 1978-11-17
FR2326191A1 (fr) 1977-04-29
SE428127B (sv) 1983-06-06
CH616424A5 (de) 1980-03-31
SE8003311L (sv) 1980-04-30
PT65619B (en) 1978-04-05
ES451746A1 (es) 1977-08-16
CA1059518A (en) 1979-07-31
SU725562A3 (ru) 1980-03-30
PH14511A (en) 1981-08-24
DE2640123A1 (de) 1977-04-07
AR213180A1 (es) 1978-12-29
ATA692376A (de) 1979-05-15
NO147027C (no) 1983-01-19
GB1510075A (en) 1978-05-10
NO147027B (no) 1982-10-11
RO69886A (ro) 1981-09-24
DK147049C (da) 1984-10-01
FI762693A (de) 1977-04-04

Similar Documents

Publication Publication Date Title
DD130857A5 (de) Verfahren zur herstellung von n-phosphonomethylglycintriestern
DD129006A5 (de) Verfahren zur herstellung von pyrimidinderivaten
AT352510B (de) Verfahren zur gewinnung von protein
AT354447B (de) Verfahren zur herstellung von indolderivaten
DD127901A5 (de) Verfahren zur herstellung von mercaptoazetidin-derivaten
DD129330A5 (de) Verfahren zur herstellung von antitumorsubstanzen
AT356132B (de) Verfahren zur herstellung von neuen pyridyl- -guanidinen
PT65628B (de) Verfahren zur bekampfung von unkraut
DD128010A5 (de) Verfahren zur aufbereitung von festem brennstoff
DD130036A5 (de) Verfahren zur herstellung von optisch aktiven 11-desoxy-16-aryloxy-omega-tetranorprostaglandinen
AT349016B (de) Verfahren zur herstellung von nicotinsaeureamid
DD129326A5 (de) Verfahren zur herstellung von 1,4-diphenyl-3-pyrazolin-5-onen
AT346304B (de) Verfahren zum herstellen von 1-phenyl-cis-2- hydroxymethyl -r-1-cyclohexanol
AT348499B (de) Verfahren zur herstellung von aethylchlorthioformiat
DD131562A5 (de) Verfahren zur herstellung von 5-pregnen-derivaten
DD129325A5 (de) Verfahren zur herstellung von 2-hydroxymethyl-3-hydroxy-6-(1-hydroxy-2-teert.-butylaminoaethyl)-pyridin
AT349015B (de) Verfahren zur gewinnung von nicotinsaeureamid
DD132294A5 (de) Verfahren zur herstellung von tabakwaren
DD122961A5 (de) Verfahren zur herstellung von diphenylaether-derivaten
AT352914B (de) Verfahren zur herstellung von polyen- verbindungen
AT346280B (de) Verfahren zur herstellung von metaboratloesungen
AT350582B (de) Verfahren zur herstellung von n-mehtyl-harn- stoffen
AT376633B (de) Verfahren zur herstellung von phosphornitriden
DD128709A5 (de) Verfahren zur herstellung von dekahydrochinolinderivaten
DD128099A1 (de) Verfahren zur herstellung von allantoin